FDA Ethical Standards Hurt By Pressure For Productivity - Reviewer
Executive Summary
The emphasis on productivity under the prescription drug user fee system is having an adverse effect on ethical standards for clinical trials, an FDA reviewer asserted in an Aug. 24 letter to The Washington Post.
You may also be interested in...
FDA ODE II Overhaul Continues: Rarick Returns, Sobel Moves Up
FDA is completing a change of the guard in the Office of Drug Evaluation II with the appointment of Reproductive & Urologic Drug Products Division Director Lisa Rarick, MD, as ODE II deputy director.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011